Search Within

Jaclyn Frances Hechtman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (65)
  2. Journal Article (63)
  3. Review (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. GSK Faculty (133)
  2. Human Oncology and Pathogenesis Program (133)
  3. Department of Pathology and Laboratory Medicine (125)
  4. Department of Medicine (112)
  5. Solid Tumor Oncology Division (112)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (90)

More Groups

People
  1. Marc Ladanyi (69)
  2. Michael Berger (66)
  3. David Solit (52)
  4. Ahmet Zehir (50)
  5. Nikolaus Schultz (47)
  6. Jinru Shia (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (10)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Modern Pathology (16)
  3. Clinical Cancer Research (12)
  4. Laboratory Investigation (11)
  5. Journal of Molecular Diagnostics (10)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (25)
  3. Nature Publishing Group (17)
  4. Nature Research (16)
  5. Elsevier Science, Inc. (11)
  6. Oxford University Press (8)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay
    Journal Article

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT
    Meeting Abstract

    Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Somatic tumor profiling of DNA mismatch repair deficient (MMR-D) colorectal cancers (CRC)
    Meeting Abstract

    Ganesh, K.; Middha, S.; Hechtman, J. F.; Ashraf, A.; Tran, C.; Villano, D.; Yaeger, R. D.; Segal, N. H.; Cercek, A.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases
    Meeting Abstract

    Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Chromosome 20q gain defines a molecular subtype associated with microsatellite stability, wild-type RAS/RAF, mutant TP53, left-sided tumors, and better overall survival in metastatic colorectal carcinoma
    Meeting Abstract

    Ptashkin, R. N.; Pagan, C.; Middha, S.; Yaeger, R.; Ladanyi, M.; Berger, M.; Zehir, A.; Hechtman, J. F.
    Journal of Molecular Diagnostics (2016)

    Fulltext@MSK | Save
  • Recurrent, truncating Sox9 mutations are associated with sox9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
    Journal Article

    Javier, B. M.; Yaeger, R.; Wang, L.; Sanchez-Vega, F.; Zehir, A.; Middha, S.; Sadowska, J.; Vakiani, E.; Shia, J.; Klimstra, D.; more...
    Oncotarget (2016)

    Fulltext@MSK | Save